FDA Approves Medicines360 ’s Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years

SAN FRANCISCO– Nov. 14, 2022 -- Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, announced today that the U.S. Food and Drug Administration (FDA) has approved...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news